Equine Metabolic Syndrome

A collection of metabolic and clinical features where insulin dysregulation (ID) is the central component.

Insulin Dysregulation (ID): Defined as a combination of resting hyperinsulinemia, postprandial hyperinsulinemia, and peripheral or hepatic insulin resistance.

Primary Risk: Significantly increases the risk of Hyperinsulinemia-Associated Laminitis (HAL).

Etiology & Pathogenesis

Underlying Cause: A disturbance in the relationship between circulating glucose and insulin.
Developmental Factors: Likely a combination of a genetic background and a diet inappropriately high in nonstructural carbohydrates (NSC).
Mechanism: Hyperinsulinemia results from excessive insulin secretion after NSC ingestion or decreased hepatic clearance; insulin resistance is the inadequate response of tissues to insulin.

Clinical Findings & Presentation

Physical Appearance:
- Obesity: Generalized overconditioning (BCS ≥ 7/9).
- Regional Adiposity: Notable fat accumulation in the neck (cresty neck), tailhead, and behind the shoulder.
- Lean Phenotype: EMS can also occur in horses that are not visibly obese.
Reproductive Signs: Geldings may show fat in the prepuce; mares may have fat around mammary glands, infertility, or irregular cycles.
Breed Predisposition: Most common in ponies, Saddlebreds, Tennessee Walking Horses, Morgans, and Mustangs.

Hyperinsulinemia-Associated Laminitis (HAL)

Significance: Represents approximately 90% of laminitis cases in the general equine population.
Nature: Often a chronic, recurring condition triggered by feeds high in soluble carbohydrates (e.g., lush spring/autumn pastures).
Pathology: Involves stretching and elongation of secondary epidermal lamellae, likely stimulated by insulin-like growth factor 1 receptors.
Visual Indicators: Abnormal hoof growth rings and radiographic evidence of third phalanx rotation.

Diagnostic Protocols:

Primary Focus: Documenting insulin dysregulation in a low-stress environment.
Fasting Insulin: A concentration > 45 mcIU/mL after a 3–6 hour fast is consistent with ID.
Dynamic Tests:
- Oral Sugar Test (OST): Administering corn syrup; insulin ≥ 45 mcIU/mL at 60–90 minutes indicates ID.
- Oral Glucose Test (OGT): Administering dextrose powder; insulin ≥ 65 mcIU/mL at 2 hours indicates ID.
Concurrent Conditions: Approximately 30% of older horses with EMS also have Pituitary Pars Intermedia Dysfunction (PPID).

Management & Treatment:

Diet (Most Critical):
- Eliminate grazing, grains, and treats.
- Provide hay low in nonstructural carbohydrates (< 10%).
- Soak hay for 60 minutes to further reduce sugar content.
Farriery: Essential regular hoof trimming (every 4 weeks) and radiography to monitor foot distortion.
Exercise: Improves insulin sensitivity by building muscle and decreasing fat.
Pharmaceuticals:
- SGLT2 Inhibitors: (e.g., velagliflozin, canagliflozin) help manage hyperinsulinemia when diet alone fails.
- Metformin: May decrease insulin concentrations despite poor absorption.
- Levothyroxine: Used to aid weight loss in obese horses (not for hypothyroidism).
Note on Supplements: Magnesium, chromium, and cinnamon have not been proven to improve insulin regulation in experimental situations.

Prevention:

Weight Maintenance: Feeding to maintain an ideal body condition rather than using arbitrary guidelines.
Pasture Management: Severe grazing restrictions, especially during times of high-soluble carbohydrate content.

Equine Metabolic Syndrome

A collection of metabolic and clinical features where insulin dysregulation (ID) is the central component.

Insulin Dysregulation (ID): Defined as a combination of resting hyperinsulinemia, postprandial hyperinsulinemia, and peripheral or hepatic insulin resistance.

Primary Risk: Significantly increases the risk of Hyperinsulinemia-Associated Laminitis (HAL).

Etiology & Pathogenesis

Underlying Cause: A disturbance in the relationship between circulating glucose and insulin.

Developmental Factors: Likely a combination of a genetic background and a diet inappropriately high in nonstructural carbohydrates (NSC).

Mechanism: Hyperinsulinemia results from excessive insulin secretion after NSC ingestion or decreased hepatic clearance; insulin resistance is the inadequate response of tissues to insulin.

Clinical Findings & Presentation

Physical Appearance:

Obesity: Generalized overconditioning (BCS ≥ 7/9).

Regional Adiposity: Notable fat accumulation in the neck (cresty neck), tailhead, and behind the shoulder.

Lean Phenotype: EMS can also occur in horses that are not visibly obese.

Reproductive Signs: Geldings may show fat in the prepuce; mares may have fat around mammary glands, infertility, or irregular cycles.

Breed Predisposition: Most common in ponies, Saddlebreds, Tennessee Walking Horses, Morgans, and Mustangs.

Hyperinsulinemia-Associated Laminitis (HAL)

Significance: Represents approximately 90% of laminitis cases in the general equine population.

Nature: Often a chronic, recurring condition triggered by feeds high in soluble carbohydrates (e.g., lush spring/autumn pastures).

Pathology: Involves stretching and elongation of secondary epidermal lamellae, likely stimulated by insulin-like growth factor 1 receptors.

Visual Indicators: Abnormal hoof growth rings and radiographic evidence of third phalanx rotation.

Diagnostic Protocols:

Primary Focus: Documenting insulin dysregulation in a low-stress environment.

Fasting Insulin: A concentration > 45 mcIU/mL after a 3–6 hour fast is consistent with ID.

Dynamic Tests:

Oral Sugar Test (OST): Administering corn syrup; insulin ≥ 45 mcIU/mL at 60–90 minutes indicates ID.

Oral Glucose Test (OGT): Administering dextrose powder; insulin ≥ 65 mcIU/mL at 2 hours indicates ID.

Concurrent Conditions: Approximately 30% of older horses with EMS also have Pituitary Pars Intermedia Dysfunction (PPID).

Management & Treatment:

Diet (Most Critical):

Eliminate grazing, grains, and treats.

Provide hay low in nonstructural carbohydrates (< 10%).

Soak hay for 60 minutes to further reduce sugar content.

Farriery: Essential regular hoof trimming (every 4 weeks) and radiography to monitor foot distortion.

Exercise: Improves insulin sensitivity by building muscle and decreasing fat.

Pharmaceuticals:

SGLT2 Inhibitors: (e.g., velagliflozin, canagliflozin) help manage hyperinsulinemia when diet alone fails.

Metformin: May decrease insulin concentrations despite poor absorption.

Levothyroxine: Used to aid weight loss in obese horses (not for hypothyroidism).

Note on Supplements: Magnesium, chromium, and cinnamon have not been proven to improve insulin regulation in experimental situations.

Prevention:

Weight Maintenance: Feeding to maintain an ideal body condition rather than using arbitrary guidelines.

Pasture Management: Severe grazing restrictions, especially during times of high-soluble carbohydrate content.